Direct targeting of BAK/BAX to inhibit cardiomyocyte apoptosis and necroptosis provides a means to limit myocardial cell apoptosis and necroptosis and therefore could potentially improve the poor prognosis of the MI/IR. Here, BAX is linked to myocardial infarction.